ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesE09.34

E09.34

Billable

Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 E09.34 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy.

Key Diagnostic Point:

E09.34 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by severe nonproliferative diabetic retinopathy. This condition arises when certain medications, such as corticosteroids or antipsychotics, lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. The severe nonproliferative diabetic retinopathy indicates significant retinal damage due to prolonged hyperglycemia, characterized by retinal hemorrhages, exudates, and microaneurysms. Management of this condition requires careful monitoring of blood glucose levels, often necessitating insulin therapy or other antidiabetic medications. Regular ophthalmologic evaluations are crucial to assess the progression of retinopathy and to implement timely interventions to prevent vision loss. The interplay between drug-induced diabetes and its complications underscores the importance of comprehensive patient management, including lifestyle modifications and potential adjustments in medication regimens.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Identification of drug-induced diabetes versus other types of diabetes
  • Need for detailed documentation of retinopathy severity
  • Differentiation from other diabetic complications
  • Understanding of medication history and its impact on diabetes management

Audit Risk Factors

  • Inadequate documentation of drug history
  • Failure to specify the severity of retinopathy
  • Misclassification of diabetes type
  • Lack of follow-up documentation for retinopathy

Specialty Focus

Medical Specialties

Endocrinology

Documentation Requirements

Thorough medication history, HbA1c levels, and detailed assessment of diabetes management.

Common Clinical Scenarios

Patients presenting with new-onset diabetes after starting corticosteroids or antipsychotics.

Billing Considerations

Endocrinologists must ensure clear documentation linking drug use to diabetes onset and monitor for complications.

Ophthalmology

Documentation Requirements

Detailed retinal examination findings, including the extent of nonproliferative changes.

Common Clinical Scenarios

Patients with diabetes presenting for routine eye exams or with vision changes.

Billing Considerations

Ophthalmologists should document the severity of retinopathy and any interventions performed.

Coding Guidelines

Inclusion Criteria

Use E09.34 When
  • According to ICD
  • 10 guidelines, E09
  • 34 should be used when diabetes is specifically induced by drugs or chemicals, and the presence of severe nonproliferative diabetic retinopathy must be documented
  • It is essential to ensure that the diabetes is not due to other causes

Exclusion Criteria

Do NOT use E09.34 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99214CPT Code

Established patient office visit, level 4

Clinical Scenario

Used for follow-up visits for diabetes management and retinopathy assessment.

Documentation Requirements

Document patient history, examination findings, and management plan.

Specialty Considerations

Endocrinologists should include medication adjustments and retinopathy monitoring.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of drug-induced diabetes, improving the accuracy of diabetes-related data and facilitating better patient management through detailed documentation of complications.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of drug-induced diabetes, improving the accuracy of diabetes-related data and facilitating better patient management through detailed documentation of complications.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of drug-induced diabetes, improving the accuracy of diabetes-related data and facilitating better patient management through detailed documentation of complications.

Resources

Clinical References

  • •
    American Diabetes Association

Coding & Billing References

  • •
    American Diabetes Association

Frequently Asked Questions

What medications can cause drug-induced diabetes?

Common medications include corticosteroids, certain antipsychotics, and some antihypertensives. It's important to review the patient's medication history to identify potential causes.